SC 46542
Latest Information Update: 23 Sep 1997
At a glance
- Originator Pharmacia Corporation
- Class Antihypertensives; Heart failure therapies
- Mechanism of Action Diuretics
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Heart failure; Hypertension
Most Recent Events
- 23 Sep 1997 No-Development-Reported for Congestive heart failure in USA (Unknown route)
- 23 Sep 1997 No-Development-Reported for Hypertension in USA (Unknown route)
- 24 Oct 1994 Preclinical development for Congestive heart failure in USA (Unknown route)